BCL-6 expression predicts improved survival in patients with primary central nervous system lymphoma.
Year: 2003
Type: article
Study design: Observational Study
Source: PubMed
Institutions: Harvard University, Massachusetts General Hospital
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Keywords: primary central nervous system lymphoma, BCL6, prognostic factors, overall survival, high-dose methotrexate, diffuse large B-cell lymphoma, B cell differentiation, histogenesis, Bcl-2, IRF4, CD10, CD44, CDKN2A/p16, Kiel classification, immunohistochemistry, fluorescence in situ hybridization
Open Access status: closed
OpenAlex ID: W2152619423
